3 Smoking-Hot Cannabis 2.0 Stocks That Could Grow Tenfold Over the Next Decade

The Canadian cannabis market shifted into a new gear with the launch of Cannabis 2.0 products in late 2019. Cannabis 2.0 products include edibles, extracts, and vaporizers. This segment of the cannabis market carries with it much higher profit margins than dried flower products do. Companies and investors are thus cautiously optimistic about a second green rush occurring. These three…

Read More

Canopy (TSX:WEED) and Aurora (TSX:ACB): Two Industry Juggernauts With Very Different Strategies

As the Canadian cannabis space has begun to enter a new phase, it is interesting to look back at how we got here. An initial frantic arms race to accumulate as much production capacity as possible eventually gave way to the reality that demand would be a lot slower to migrate to the legal market than market participants had hoped.…

Read More

Should You Buy Canopy Growth (TSX:WEED) or Aurora Cannabis (TSX:ACB) Stock?

Everyone knows that diversification is key to investing, as it protects investors from too much exposure into one specific sector. Having cannabis stocks in your portfolio may be a great idea if you are looking for a well-rounded portfolio. In Canada, marijuana has been legalized for medical use since 2001 and recreational use since 2018. This has allowed the industry…

Read More

Canopy Growth (TSX:WEED) Stock: $0 or $100?

Industries across the board continue to suffer thanks to the COVID-19 pandemic. It seems no industry immune to the financial devastation it can cause, including the cannabis industry. Despite the increase in demand and sales of cannabis while people stay home, that hasn’t fixed the problem cannabis suppliers like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) continue to have: a means of supplying that…

Read More

My Top Cannabis Pick

This recent market turmoil has resulted in what I can only describe as a tectonic shift in the Canadian cannabis sector. Investors have moved from a growth-at-any-cost, risk-seeking base of retail investors to a much more conservative, long-term group of investors. Stock prices tell this story. In this article, I’m going to discuss why, despite more downside likely on the…

Read More

What Should Investors Expect From Canopy Growth (TSX:WEED) Stock?

Cannabis investors punished Canopy Growth (TSX:WEED)(NYSE:CGC) after a worse-than-expected earnings report revealing deep cracks in the industry. Canopy plunged as a result. For once, though, the drop looks less like a value opportunity than a wake-up call. But what’s the outlook for this cannabis stock, and why are investors so divided on its outlook? Let’s take a look. Is Canopy…

Read More

The Constellation Investment Is Proving to Be Canopy’s (TSX:WEED) Most Significant Competitive Advantage

You may have seen the recent news about Constellation (NYSE:STZ) exercising warrants to acquire additional shares in Canopy (TSX:WEED)(NYSE:CGC). This announcement was easy to overlook, partly because of its timing (the announcement came out after markets closed on a Friday), partly because Constellation is already Canopy’s largest shareholder, and mostly because of everything else happening in the world right now.…

Read More

Canopy Growth (TSX:WEED) Stock: Is the End Near?

If there’s one industry that has been incredibly frustrating for investors of late, it’s the cannabis industry. Canopy Growth (TSX:WEED)(NYSE:CGC) in particular used to be the darling of the industry, but that has all changed. WEED stock plummeted from all-time highs back in October 2018 after legalization. Since then, WEED stock has struggled to get anywhere near those highs again. Then, the…

Read More

Canopy Growth Stock Lagged the TSX by 5.7% in March

Canopy Growth (TSX:WEED)(NYSE:CGC) stock price was already in the throes of despair before the coronavirus crisis. The stock had already fallen dramatically from late 2018/early 2019 highs as the cannabis bubble burst. In March, Canopy Growth stock price continued to underperform the TSX, lagging it by 5.7%. During the month of March, all eyes were on developments related to the…

Read More

Coronavirus Market Meltdown: Buy Canopy Growth Stock for Defensive Pot Status

Speculations on whether the cannabis industry is a defensive, non-cyclical consumer staple producer with resilient sales that remain strong during economic recessions will settle when financial results for the first calendar quarter of 2020 start creeping in. Until then, should cannabis investors consider industry leader Canopy Growth’s (TSX:WEED)(NYSE:CGC) stock a defensive play during the ongoing coronavirus-induced economic meltdown? Canopy Growth…

Read More